CARE Ratings FY26 Profit ₹174 Cr; Dividend ₹14 Declared, Subsidiary Sale Faces Delays

BANKINGFINANCE
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
CARE Ratings FY26 Profit ₹174 Cr; Dividend ₹14 Declared, Subsidiary Sale Faces Delays
Overview

CARE Ratings announced strong audited FY26 results, with a consolidated profit of ₹173.70 crore on ₹473.07 crore revenue. The board proposed a ₹14 final dividend and reappointed BSR & Co. LLP as auditors for five years. However, progress on selling a stake in its subsidiary, CareEdge Global IFSC, is slow.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

FY26 Financial Results and Dividend

CARE Ratings announced its audited financial results for the fiscal year ending March 31, 2026. The company reported a consolidated net profit of ₹173.70 crore on consolidated revenue of ₹473.07 crore. On a standalone basis, the company posted a net profit of ₹174.39 crore on revenue of ₹387.72 crore. The Board has recommended a final dividend of ₹14 per equity share for FY26.

Key Announcements

The Board of Directors, meeting on May 13, 2026, approved these results. Alongside the financial outcomes, the board reappointed BSR & Co. LLP as statutory auditors for a five-year term, pending shareholder approval. The company also approved granting 55,000 stock options to employees under its Employee Stock Option Plan (ESOP).

Significance of Results and Decisions

CARE Ratings' robust financial performance underscores its strong market position in the credit rating sector. The recommended ₹14 dividend offers a direct return to shareholders. Reappointing auditors for a five-year term provides continuity and reinforces investor confidence in regulatory compliance. The stock options are intended to attract and retain key employees.

Subsidiary Stake Sale Progress

Discussions for the partial sale of CARE Ratings' subsidiary, CareEdge Global IFSC Limited, to potential partners including State Bank of India and NSE IFSC, have been underway. While intended to unlock strategic value, reports suggest these talks are progressing slowly, possibly due to complexities in the deal structure.

Outlook and Shareholder Impact

Shareholders can anticipate receiving the proposed ₹14 final dividend for FY26, pending approval at the Annual General Meeting (AGM). The reappointment of BSR & Co. LLP ensures continued auditing services for the next five years. Granting stock options aims to align employee interests with the company's long-term growth.

Ongoing Challenges

The ongoing negotiations for the partial stake sale in CareEdge Global IFSC Limited, involving parties like State Bank of India and NSE IFSC, are taking longer than expected. This extended timeline could affect the strategic objectives planned for the subsidiary.

Competitive Landscape

CARE Ratings operates within a competitive market, alongside other major credit rating agencies like ICRA Ltd. and CRISIL Ltd., which also serve Indian businesses and financial institutions.

Financial Highlights

Key Financials for FY26: Consolidated revenue reached ₹473.07 crore, consolidated net profit was ₹173.70 crore, and standalone net profit stood at ₹174.39 crore.

Looking Ahead

Investors will be watching for shareholder approval of the dividend and auditor reappointment at the upcoming AGM. Updates on the CareEdge Global IFSC stake sale timeline will also be key. Management's commentary on future growth drivers and strategic initiatives during the next earnings call will provide further insight.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.